Drug data last refreshed 17h ago · AI intelligence enriched 3w ago
Technetium Tc-99m Pentetate is a radiopharmaceutical diagnostic imaging agent used for renal imaging, cardiac blood pool studies, and other nuclear medicine applications. It is a kit-based injectable that requires reconstitution with pertechnetate before administration. The agent works by accumulating in specific tissues, enabling visualization via gamma camera imaging.
Product approaching loss of exclusivity with moderate competitive pressure (30%), indicating a shrinking commercial footprint and likely reduced team investment.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
This product offers limited career growth opportunity given its LOE-approaching lifecycle and zero linked jobs in the market. Roles available are primarily focused on operational efficiency, regulatory maintenance, and managed decline rather than innovation or expansion.
Worked on TECHNETIUM TC-99M PENTETATE KIT at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.